Applied StemCell (Gene Editing Platform and Oncology Product Portfolio) is Buildings and Property in United States that focus on oncology product portfolio business. They cover business area such as Milpitas, California, cell line, disease, therapeutic drug discovery.
-
Oncology Product Portfolio
-
521 Cottonwood Drive
Suite 111
Milpitas, CA 95035
United States
Private
MilpitasCaliforniacell linediseasetherapeutic drug discovery
* We use standard office opening hours in near Applied StemCell (Gene Editing Platform and Oncology Product Portfolio)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Applied StemCell (Gene Editing Platform And Oncology Product Portfolio) is Buildings and Property business from United States that founded in - ( years old in ), Applied StemCell (Gene Editing Platform and Oncology Product Portfolio) business is focusing on Oncology Product Portfolio.
Applied StemCell (Gene Editing Platform and Oncology Product Portfolio) headquarter office and corporate office address is located in 521 Cottonwood Drive Suite 111 Milpitas, CA 95035 United States.
Applied StemCell (Gene Editing Platform and Oncology Product Portfolio) was founded in United States.
In , Applied StemCell (Gene Editing Platform and Oncology Product Portfolio) is currently focus on oncology product portfolio sector.
Above is snippet of Google Trends for "oncology product portfolio" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Applied StemCell (Gene Editing Platform and Oncology Product Portfolio), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
